Director Leslie J Parrette buys 340 IOSP shares at $74.09; stock down 40.8% from 52-week high.
Director Leslie J Parrette purchased 340 shares of Innospec Inc. at $74.09 on 2025-11-14, increasing holdings by 6.2% to 5,837 shares. The transaction occurs while the stock trades at $72.23, down 40.8% from its 52-week high of $121.93 and down 14.2% over the prior 90 days. Across his same-ticker history at IOSP, Parrette's prior four purchases show a 75% win rate at the 90-day mark (3 of 4 buys followed by positive returns), with returns ranging from +0.7% to +17.5% on the successful trades. However, the company's fundamentals show stress: annual revenue declined 5.3% year-over-year, and the P/E of 50.51 remains elevated despite the recent stock decline, suggesting limited margin of safety at current valuation.
Director Leslie J Parrette bought 143 IOSP shares at $105.84 on 2024-08-13, +3.1% of holdings; stock down 18.4% from 52-week high.
Director Parrette purchased 143 shares at $105.84, increasing holdings by 3.1% to 4,734 shares. The timing of this buy merits scrutiny: the prior buy at this ticker on 2024-05-16 returned -18.4% over 90 days, and the current stock is already down 18.4% from its 52-week high of $131.58 while also declining 14.4% over the last 30 days. Among his three prior IOSP trades, two were well-timed at the 90-day mark (2024-02-22 and 2023-05-10 both delivered positive 90-day returns), but the most recent buy (2024-05-16) suffered a sharp decline. The company fundamentals remain modest—revenue growth is flat at -0.8% year-over-year with a P/E of 17.90—and the position size remains small relative to the director's prior accumulation pattern. This transaction occurs against a backdrop of near-term weakness and provides limited material signal about conviction given the mixed outcome history at this specific ticker.
